
EUDR ‘no risk’ status cancelled and 12 month delay reconfirmed
The controversial EUDR no risk status has been provisionally binned in a ‘trilogue’ between the European Council, Commission and Parliament.

The controversial EUDR no risk status has been provisionally binned in a ‘trilogue’ between the European Council, Commission and Parliament.

The brand says its latest innovation offers a clinically-supported probiotic that is an effective and affordable option for women seeking to help stabilize hormone imbalance.

This fall, a number of industry veterans stepped into new roles to contribute to global expansion strategies and propel research-based product development in a competitive dietary supplement space.

In this guest article, Dr. Andrea Wong discusses the Council for Responsible Nutrition’s initiatives, from best practices for specific ingredient and product categories to a dietary supplement product registry.

Low daily doses of a proprietary ashwagandha root and leaf extract may reduce anxiety by almost 60% and stress by over 65%, says a new study from India.

The IPA World Congress + Probiota 2025 is two months away! The three-day conference is the leading event for the probiotics, prebiotics, and microbiome community, and here’s why…

The French startup has introduced a novel way for wellness consumers to get their daily dose of vitamins and minerals.

Probiotic strain Lacticaseibacillus rhamnosus IDCC 3201 (RH 3201) can improve symptoms of irritable bowel syndrome with constipation (IBS-C), according to RCT findings.

As consumer demand for novelty and health-focused offerings continues to grow, Japanese brands are finding renewed optimism to bring authentic and innovative products into the Asia Pacific market.